Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$171.47
À la fermeture: Aug 28 EDT
$171.47
0.000.00%
Pré-commercialisation: 4:11 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
iRhythm Technologies Inc a un objectif de cours consensus de $158.23, basé sur les évaluations des 13 analystes. Le plus élevé est de $200 attribué par B of A Securities le août 20, 2025, et le plus bas est de $115 attribué par Wolfe Research le juin 20, 2024. Les 3 dernières évaluations d'analystes ont été publiées par Needham, Citigroup et B of A Securities le août 28, 2025, août 21, 2025 et août 20, 2025. Avec un objectif de cours moyen de $192 entre Needham, Citigroup et B of A Securities, il y a une variation implicite de 11.97% upside pour iRhythm Technologies Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Needham
Citigroup
B of A Securities
JP Morgan
Canaccord Genuity
1calculé à partir des notes des analystes
Notes d'analystes pour iRhythm Technologies
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/28/2025 | 12.56% | Needham | $180 → $193 | Maintains | Buy | |||
08/21/2025 | 6.72% | Citigroup | $167 → $183 | Maintains | Buy | |||
08/20/2025 | 16.64% | B of A Securities | → $200 | Initiates | → Buy | |||
08/01/2025 | 10.81% | JP Morgan | $145 → $190 | Maintains | Overweight | |||
08/01/2025 | -0.86% | Canaccord Genuity | $139 → $170 | Maintains | Buy | |||
08/01/2025 | 4.97% | Wells Fargo | $130 → $180 | Maintains | Overweight | |||
08/01/2025 | 4.97% | Needham | $151 → $180 | Maintains | Buy | |||
07/15/2025 | -14.27% | Morgan Stanley | $160 → $147 | Maintains | Overweight | |||
06/11/2025 | -6.69% | Morgan Stanley | $130 → $160 | Maintains | Overweight | |||
05/22/2025 | -2.61% | Citigroup | $130 → $167 | Maintains | Buy | |||
05/02/2025 | -18.94% | Canaccord Genuity | $152 → $139 | Maintains | Buy | |||
05/02/2025 | -24.18% | Wells Fargo | $104 → $130 | Upgrade | Equal-Weight → Overweight | |||
05/02/2025 | -12.52% | Baird | $133 → $150 | Maintains | Outperform | |||
05/02/2025 | -11.94% | Needham | $138 → $151 | Maintains | Buy | |||
02/24/2025 | -27.68% | Goldman Sachs | $91 → $124 | Maintains | Neutral | |||
02/21/2025 | -24.18% | Citigroup | $100 → $130 | Maintains | Buy | |||
02/21/2025 | -15.44% | Truist Securities | $111 → $145 | Maintains | Buy | |||
02/21/2025 | -39.35% | Wells Fargo | $86 → $104 | Maintains | Equal-Weight | |||
02/21/2025 | -19.52% | Needham | $125 → $138 | Maintains | Buy | |||
01/17/2025 | -27.1% | Needham | $112 → $125 | Maintains | Buy | |||
01/13/2025 | -34.68% | Needham | $96 → $112 | Maintains | Buy | |||
01/08/2025 | -30.02% | Oppenheimer | $105 → $120 | Maintains | Outperform | |||
12/18/2024 | -35.27% | Truist Securities | $85 → $111 | Maintains | Buy | |||
12/09/2024 | -11.35% | Canaccord Genuity | $125 → $152 | Maintains | Buy | |||
12/03/2024 | -49.85% | Wells Fargo | → $86 | Reinstates | → Equal-Weight | |||
11/01/2024 | -53.93% | Baird | $100 → $79 | Maintains | Outperform | |||
10/31/2024 | -44.01% | Needham | $119 → $96 | Maintains | Buy | |||
10/22/2024 | -44.6% | Truist Securities | $80 → $95 | Maintains | Buy | |||
10/14/2024 | -53.34% | Truist Securities | $117 → $80 | Maintains | Buy | |||
10/04/2024 | -54.51% | Goldman Sachs | → $78 | Initiates | → Neutral | |||
09/25/2024 | -20.1% | Canaccord Genuity | $122 → $137 | Maintains | Buy | |||
08/22/2024 | -35.85% | Citigroup | $135 → $110 | Maintains | Buy | |||
08/02/2024 | -41.68% | JP Morgan | $133 → $100 | Maintains | Overweight | |||
08/02/2024 | -15.44% | Oppenheimer | $165 → $145 | Maintains | Outperform | |||
08/02/2024 | -35.85% | Baird | $120 → $110 | Maintains | Outperform | |||
08/02/2024 | -31.77% | Truist Securities | $134 → $117 | Reiterates | Buy → Buy | |||
08/02/2024 | -30.6% | Needham | $138 → $119 | Maintains | Buy | |||
07/16/2024 | -21.85% | Truist Securities | $145 → $134 | Maintains | Buy | |||
07/15/2024 | -24.18% | Morgan Stanley | $135 → $130 | Maintains | Overweight | |||
06/20/2024 | -32.93% | Wolfe Research | → $115 | Upgrade | Peer Perform → Outperform | |||
05/03/2024 | -28.85% | Canaccord Genuity | $133 → $122 | Maintains | Buy | |||
05/03/2024 | -19.52% | Needham | $137 → $138 | Maintains | Buy | |||
02/23/2024 | -22.44% | JP Morgan | $142 → $133 | Maintains | Overweight | |||
02/23/2024 | -22.44% | Canaccord Genuity | $121 → $133 | Maintains | Buy | |||
02/23/2024 | -20.1% | Needham | $136 → $137 | Maintains | Buy | |||
01/08/2024 | -20.69% | Needham | $108 → $136 | Maintains | Buy | |||
12/22/2023 | -22.44% | Truist Securities | $115 → $133 | Maintains | Buy | |||
12/12/2023 | -32.93% | Truist Securities | $100 → $115 | Maintains | Buy | |||
12/11/2023 | -35.85% | Citigroup | → $110 | Upgrade | Neutral → Buy | |||
11/03/2023 | -37.02% | Needham | $140 → $108 | Maintains | Buy | |||
10/11/2023 | -21.27% | Morgan Stanley | $149 → $135 | Maintains | Overweight | |||
08/28/2023 | -32.35% | Canaccord Genuity | $136 → $116 | Maintains | Buy | |||
08/07/2023 | -19.52% | Truist Securities | $155 → $138 | Maintains | Buy | |||
08/04/2023 | -13.1% | Morgan Stanley | $149 → $149 | Reiterates | Overweight → Overweight | |||
08/04/2023 | -24.18% | Needham | $151 → $130 | Maintains | Buy | |||
07/19/2023 | -24.18% | Baird | → $130 | Initiates | → Outperform | |||
07/11/2023 | -13.1% | Morgan Stanley | $149 → $149 | Reiterates | Overweight → Overweight | |||
06/08/2023 | -18.35% | BTIG | $165 → $140 | Maintains | Buy | |||
06/07/2023 | -27.1% | Oppenheimer | $166 → $125 | Maintains | Outperform | |||
06/07/2023 | -10.77% | Canaccord Genuity | → $153 | Reiterates | Buy → Buy | |||
06/07/2023 | -32.93% | Citigroup | $135 → $115 | Maintains | Neutral | |||
05/05/2023 | -13.1% | Morgan Stanley | $130 → $149 | Maintains | Overweight | |||
05/05/2023 | -9.61% | Truist Securities | $154 → $155 | Maintains | Buy | |||
05/05/2023 | -21.27% | Citigroup | $130 → $135 | Maintains | Neutral | |||
05/05/2023 | -11.94% | Needham | $133 → $151 | Maintains | Buy | |||
04/17/2023 | -10.19% | Truist Securities | $137 → $154 | Maintains | Buy | |||
04/17/2023 | -0.86% | BTIG | $168 → $170 | Maintains | Buy | |||
04/03/2023 | -24.18% | Citigroup | $110 → $130 | Maintains | Neutral | |||
02/24/2023 | -16.6% | Canaccord Genuity | $135 → $143 | Maintains | Buy | |||
02/24/2023 | -24.18% | Morgan Stanley | $128 → $130 | Maintains | Overweight | |||
02/24/2023 | -22.44% | Needham | $140 → $133 | Maintains | Buy | |||
02/07/2023 | -12.52% | Wells Fargo | → $150 | Initiates | → Overweight | |||
01/06/2023 | -25.35% | Morgan Stanley | $165 → $128 | Maintains | Overweight | |||
12/20/2022 | -10.77% | Truist Securities | $167 → $153 | Maintains | Buy | |||
12/12/2022 | -35.85% | Citigroup | $144 → $110 | Maintains | Neutral | |||
11/02/2022 | -16.02% | Citigroup | $147 → $144 | Maintains | Neutral | |||
11/02/2022 | -18.35% | Needham | $185 → $140 | Maintains | Buy | |||
10/17/2022 | -2.61% | Truist Securities | $185 → $167 | Maintains | Buy | |||
10/11/2022 | -3.77% | Morgan Stanley | $172 → $165 | Maintains | Overweight | |||
09/22/2022 | 0.31% | Morgan Stanley | $190 → $172 | Maintains | Overweight | |||
09/22/2022 | 10.81% | JP Morgan | $185 → $190 | Maintains | Overweight | |||
09/02/2022 | 15.47% | Canaccord Genuity | $185 → $198 | Maintains | Buy |
FAQ
Quel est le cours indicatif de l'action iRhythm Technologies (IRTC) ?
Le dernier objectif de prix pour iRhythm Technologies (NASDAQ:IRTC) a été rapporté par Needham le août 28, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $193.00 s'attendant à ce que IRTC se rise dans les 12 prochains mois (un possible changement de 12.56% upside). 31 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour iRhythm Technologies (IRTC) ?
La dernière note d'analyste pour iRhythm Technologies (NASDAQ:IRTC) a été fournie par Needham, et iRhythm Technologies maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour iRhythm Technologies (IRTC) ?
La dernière amélioration pour iRhythm Technologies Inc a eu lieu le mai 2, 2025 lorsque Wells Fargo a augmenté leur objectif de prix à $130. Wells Fargo avait précédemment an equal-weight pour iRhythm Technologies Inc.
Quand a eu lieu la dernière dégradation pour iRhythm Technologies (IRTC) ?
Il n'y a pas de dernière réduction pour iRhythm Technologies.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour iRhythm Technologies (IRTC) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de iRhythm Technologies, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour iRhythm Technologies a été déposée le août 28, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers août 28, 2026.
La note d'analyste pour iRhythm Technologies (IRTC) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de iRhythm Technologies (IRTC) était un maintenu avec un objectif de prix de $180.00 à $193.00. Le prix actuel de iRhythm Technologies (IRTC) est de $171.47, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.